Episode

Ep188: Art Krieg on Innate Immune System Activators for Cancer

Podcast: The Long Run with Luke Timmerman
Published: Oct 28, 2025
Duration seconds: 4145
Processing state: not_requested
Canonical source: https://soundcloud.com/longrunpodcast/ep188-art-krieg-on-innate-immune-system-activators-for-cancer
Audio: https://feeds.soundcloud.com/stream/2200719923-longrunpodcast-ep188-art-krieg-on-innate-immune-system-activators-for-cancer.mp3
JSON: /v1/public/podcasts/the-long-run-with-luke-timmerman-1124799/episodes/ep188-art-krieg-on-innate-immune-system-activators-for-cancer
Markdown: /podcast/the-long-run-with-luke-timmerman-1124799/ep188-art-krieg-on-innate-immune-system-activators-for-cancer.md

Actions

POST https://stenobird.com/v1/public/podcasts/the-long-run-with-luke-timmerman-1124799/episodes/ep188-art-krieg-on-innate-immune-system-activators-for-cancer/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/the-long-run-with-luke-timmerman-1124799/ep188-art-krieg-on-innate-immune-system-activators-for-cancer.md
Read the agent-friendly Markdown representation of this episode resource.

Art Krieg, founder and CEO of Zola Therapeutics, on developing innate immune system activators for cancer.